Efficacy and safety of everolimus-eluting stents compared to the other drug-eluting stents (paclitaxel, sirolimus, zotarolimus, biolimus) in the treatment of coronary artery disease.
Phase of Trial: Phase IV
Latest Information Update: 23 Dec 2015
At a glance
- Drugs Everolimus (Primary) ; Paclitaxel; Sirolimus; Umirolimus; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2015 New trial record